Frank Po-Yen Lin

13PUBLICATIONS

63CO-AUTHORS

Predictive and prognostic markersCancer geneticsCancer diagnosisHaematological tumoursMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (13)

Sort by Publication Date:

|Jun 16, 2026

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

|May 26, 2026

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.

|Feb 13, 2026

Exceptional Response to Durvalumab and Tremelimumab in Pancreatic Acinar Cell Carcinoma With Ultramutated Phenotype Associated With a DNA Polymerase-ε Mutation.

Benjamin Koh, Subotheni Thavaneswaran, Frank Lin

|Jan 02, 2026

A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.

Gregory M Cote, Mason Aberoumand, Edwin Choy

|Apr 16, 2025

Clinical Impact of Somatic Genomic Variants of Oncogenes and Tumor Suppressor Genes in Previously Treated Advanced Non-Small Cell Lung Cancer.

Deborah Di-Xin Zhou, Janene Dalrymple, Danielle Klingberg

|Sep 09, 2024

A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation.

Subotheni Thavaneswaran, Frank Lin, John P Grady

Pageof 3

Frequent Collaborators

5 joint publications

David Thomas

5 joint publications

Robert John Simes

4 joint publications

Subotheni Thavaneswaran

Mandy L Ballinger

David Espinoza

Derrick H W Siu

John P Grady

Jayesh Desai

Yi Li

Ewa M Goldys

Frequent Collaborators

5 joint publications

David Thomas

5 joint publications

Robert John Simes

4 joint publications

Subotheni Thavaneswaran

3 joint publications

Mandy L Ballinger